Literature DB >> 11938673

Inhibition of HIV-1 reverse transcriptase by aryl-substituted naphto- and anthraquinones.

T V Ilina1, E A Semenova, T R Pronyaeva, A G Pokrovskii, I V Nechepurenko, E E Shults, O I Andreeva, S N Kochetkov, G A Tolstikov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11938673     DOI： 10.1023/a:1014467509828

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  8 in total

1.  Comparative Quantitative Structureminus signActivity Relationship Studies on Anti-HIV Drugs.

Authors:  Rajni Garg; Satya P. Gupta; Hua Gao; Mekapati Suresh Babu; Asim Kumar Debnath; Corwin Hansch
Journal:  Chem Rev       Date:  1999-12-08       Impact factor: 60.622

2.  Phenanthrenequinone antiretroviral agents.

Authors:  G A Kraus; A Melekhov; S Carpenter; Y Wannemuhler; J Petrich
Journal:  Bioorg Med Chem Lett       Date:  2000-01-03       Impact factor: 2.823

3.  HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.

Authors:  B A Larder; G Darby; D D Richman
Journal:  Science       Date:  1989-03-31       Impact factor: 47.728

4.  Anthraquinones as a new class of antiviral agents against human immunodeficiency virus.

Authors:  R F Schinazi; C K Chu; J R Babu; B J Oswald; V Saalmann; D L Cannon; B F Eriksson; M Nasr
Journal:  Antiviral Res       Date:  1990-05       Impact factor: 5.970

5.  Antiretroviral activities of anthraquinones and their inhibitory effects on reverse transcriptase.

Authors:  H Higuchi; K Mori; A Kato; T Ohkuma; T Endo; H Kaji; A Kaji
Journal:  Antiviral Res       Date:  1991 Mar-Apr       Impact factor: 5.970

6.  [Stability of human immunodeficiency virus to azidothymidine. II. Kinetic characteristics of "AZT-resistant" mutant forms of reverse transcriptase].

Authors:  D K Pokholok; S O Gudima; L V Memelova; D S Esipov; V O Rechinskiĭ; S N Kochetkov
Journal:  Biokhimiia       Date:  1996-01

7.  Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor.

Authors:  L A Kohlstaedt; J Wang; J M Friedman; P A Rice; T A Steitz
Journal:  Science       Date:  1992-06-26       Impact factor: 47.728

Review 8.  The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection.

Authors:  E De Clercq
Journal:  Antiviral Res       Date:  1998-06       Impact factor: 5.970
  8 in total
  4 in total

1.  Anticancer activity and SAR studies of substituted 1,4-naphthoquinones.

Authors:  Deepak Bhasin; Somsundaram N Chettiar; Jonathan P Etter; May Mok; Pui-Kai Li
Journal:  Bioorg Med Chem       Date:  2013-05-18       Impact factor: 3.641

2.  Aromatase inhibitory activity of 1,4-naphthoquinone derivatives and QSAR study.

Authors:  Veda Prachayasittikul; Ratchanok Pingaew; Apilak Worachartcheewan; Somkid Sitthimonchai; Chanin Nantasenamat; Supaluk Prachayasittikul; Somsak Ruchirawat; Virapong Prachayasittikul
Journal:  EXCLI J       Date:  2017-05-16       Impact factor: 4.068

3.  Synthesis of Selenium-Quinone Hybrid Compounds with Potential Antitumor Activity via Rh-Catalyzed C-H Bond Activation and Click Reactions.

Authors:  Guilherme A M Jardim; Daisy J B Lima; Wagner O Valença; Daisy J B Lima; Bruno C Cavalcanti; Claudia Pessoa; Jamal Rafique; Antonio L Braga; Claus Jacob; Eufrânio N da Silva Júnior; Eduardo H G da Cruz
Journal:  Molecules       Date:  2017-12-30       Impact factor: 4.411

4.  Ionically Crosslinked Chitosan Membranes Used as Drug Carriers for Cancer Therapy Application.

Authors:  Alecsandra Ferreira Tomaz; Sandra Maria Sobral de Carvalho; Rossemberg Cardoso Barbosa; Suédina M L Silva; Marcos Antônio Sabino Gutierrez; Antônio Gilson B de Lima; Marcus Vinícius L Fook
Journal:  Materials (Basel)       Date:  2018-10-20       Impact factor: 3.623
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.